Girard Partners LTD. Raises Stake in CME Group Inc. (CME)
Girard Partners LTD. raised its position in CME Group Inc. (NASDAQ:CME) by 27.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,847 shares of the financial services provider’s stock after buying an additional 613 shares during the period. Girard Partners LTD.’s holdings in CME Group were worth $357,000 as of its most recent filing with the SEC.
Other hedge funds have also bought and sold shares of the company. Exane Derivatives increased its position in shares of CME Group by 26.1% in the first quarter. Exane Derivatives now owns 6,380 shares of the financial services provider’s stock valued at $758,000 after buying an additional 1,322 shares during the last quarter. Oregon Public Employees Retirement Fund increased its position in shares of CME Group by 2.4% in the first quarter. Oregon Public Employees Retirement Fund now owns 35,589 shares of the financial services provider’s stock valued at $4,228,000 after buying an additional 836 shares during the last quarter. Parsons Capital Management Inc. RI purchased a new position in shares of CME Group during the first quarter valued at approximately $569,000. Dowling & Yahnke LLC increased its position in shares of CME Group by 1.7% in the first quarter. Dowling & Yahnke LLC now owns 6,844 shares of the financial services provider’s stock valued at $813,000 after buying an additional 114 shares during the last quarter. Finally, Capital Advisors Inc. OK increased its position in shares of CME Group by 2.0% in the first quarter. Capital Advisors Inc. OK now owns 76,335 shares of the financial services provider’s stock valued at $9,069,000 after buying an additional 1,471 shares during the last quarter. Hedge funds and other institutional investors own 82.66% of the company’s stock.
Shares of CME Group Inc. (NASDAQ:CME) opened at 126.93 on Tuesday. The stock has a market capitalization of $43.15 billion, a PE ratio of 25.91 and a beta of 0.73. CME Group Inc. has a 52-week low of $98.95 and a 52-week high of $127.96. The firm has a 50-day moving average of $123.67 and a 200 day moving average of $121.36.
CME Group (NASDAQ:CME) last announced its quarterly earnings data on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.20 by $0.03. The business had revenue of $925 million for the quarter, compared to analyst estimates of $931.05 million. CME Group had a net margin of 46.05% and a return on equity of 7.61%. The company’s revenue was up 2.1% on a year-over-year basis. During the same period in the prior year, the firm posted $1.14 EPS. Equities research analysts forecast that CME Group Inc. will post $4.80 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 25th. Stockholders of record on Friday, September 8th will be issued a dividend of $0.66 per share. The ex-dividend date is Thursday, September 7th. This represents a $2.64 annualized dividend and a dividend yield of 2.08%. CME Group’s payout ratio is currently 53.99%.
Several brokerages recently commented on CME. Royal Bank Of Canada upped their price target on shares of CME Group from $130.00 to $135.00 and gave the company an “outperform” rating in a report on Tuesday, June 20th. Deutsche Bank AG cut their price target on shares of CME Group from $139.00 to $136.00 and set a “buy” rating on the stock in a report on Tuesday, July 4th. BidaskClub upgraded shares of CME Group from a “hold” rating to a “buy” rating in a report on Friday, August 18th. Keefe, Bruyette & Woods reiterated a “hold” rating and set a $127.00 price target on shares of CME Group in a report on Friday, August 18th. Finally, Jefferies Group LLC reiterated a “buy” rating and set a $128.00 price target on shares of CME Group in a report on Monday, July 10th. One analyst has rated the stock with a sell rating, two have given a hold rating and six have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $131.63.
In other news, CFO John W. Pietrowicz sold 2,500 shares of the stock in a transaction dated Monday, July 10th. The shares were sold at an average price of $124.50, for a total transaction of $311,250.00. Following the transaction, the chief financial officer now directly owns 38,495 shares in the company, valued at approximately $4,792,627.50. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Martin J. Gepsman sold 200 shares of the stock in a transaction dated Wednesday, August 9th. The stock was sold at an average price of $126.14, for a total transaction of $25,228.00. Following the transaction, the director now owns 43,311 shares in the company, valued at $5,463,249.54. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 80,820 shares of company stock worth $10,033,166. Insiders own 0.57% of the company’s stock.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.